| 21/03 | Blue shield of california - low-cost insulin one step closer with california-civica par.. |  |
| 21/03 | Fed Policy Meeting, Banks in Focus as Exchange-Traded Funds, Equity Futures Rise Premar.. | |
| 21/03 | Sanofi, Regeneron Pharmaceuticals Say Dupixent Obtains European Approval to Treat Sever.. | |
| 21/03 | Bolsa de Madrid: Cueste lo que cueste... |  |
| 21/03 | Sanofi, Regeneron's Dupixent Wins EU's First-in-Class Nod for Severe Atopic Dermatitis .. | |
| 21/03 | Press Release : Dupixent® (dupilumab) approved by European Commission as first and only ta.. | |
| 21/03 | Press Release : Dupixent® (dupilumab) approved by European Commission as first and only ta.. | |
| 21/03 | European Commission Approves Dupixent of Regeneron Pharmaceuticals, Inc. and Sanofi | |
| 20/03 | Vaccine makers prep bird flu shots for humans | |
| 20/03 | Bolsa de Madrid: Otro banco que muerde el polvo | |
| 20/03 | Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in suppl.. | |
| 18/03 | Press Release : Dupixent® (dupilumab) late-breaking data at AAD show significant improveme.. | |
| 18/03 | Press Release : Dupixent® (dupilumab) late-breaking data at AAD show significant improveme.. | |
| 17/03 | Healthcare Shares Decline With Focus on Drug Prices - Healthcare Roundup | |
| 17/03 | Borse Europa in rialzo su minori turbolenze bancarie, bene energia |  |
| 17/03 | Bolsa de Madrid: ¿Fin de la Berezina? | |
| 17/03 | MORNING BRIEFING - Deutschland/Europa -2- |  |
| 17/03 | MORNING BRIEFING - USA/Asien -2- | |
| 17/03 | Marketmind: Support for troubled banks calms markets | |
| 17/03 | France's Sanofi Joins Rivals in Slashing US Insulin Prices | |
| 17/03 | Sanofi cuts insulin cost to $35, third major drug company to do so | |
| 16/03 | Sanofi to cut US price of its most-prescribed insulin by 78% | |
| 16/03 | Diabetes-Medikamentenriese Sanofi senkt Insulinpreise drastisch | |
| 16/03 | Sanofi Cuts Lantus US List Price by 78%, Caps Insured Out-of-Pocket Cost to $35 | |
| 16/03 | Sanofi to cut price of its most-prescribed insulin by 78% in US | |
| 16/03 | Sanofi Cuts US Price of Lantus Insulin by 78% | |
| 16/03 | Sanofi Cuts US Price of Lantus Insulin by 78% | |
| 16/03 | Press Release : Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78.. | |
| 16/03 | Press Release : Sanofi cuts U.S. list price of Lantus®, its most-prescribed insulin, by 78.. | |
| 14/03 | Sanofi Announces Acceptance of Dupixent Application for Treatment of Chronic Spontaneou.. | |
| 14/03 | Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifyi.. | |
| 14/03 | Novo Nordisk senkt Insulinpreise ab 2024 um bis zu 75 Prozent | |
| 14/03 | Novo Nordisk planea reducir hasta un 75% el precio de la insulina en EEUU | |
| 13/03 | Healthcare Shares Climb Amid Deal News -- Healthcare Roundup | |
| 13/03 | Aktien New York Schluss: Stabilisierung - Übernahmen stützen Nas.. | |
| 13/03 | MÄRKTE USA/Wall Street uneinheitlich - Bankenwerte stürzen ab | |
| 13/03 | Bankendrama zet Wall Street onder druk |  |
| 13/03 | Sector Update: Health Care Stocks Close with Solid Monday Gains | |
| 13/03 | Sector Update: Health Care Maintaining Monday Rebound | |
| 13/03 | Aktien New York: Stabilisierung trotz Bankenkrise - Übernahmen beflügen .. | |
| 13/03 | Top Midday Gainers | |
| 13/03 | Sector Update: Health Care | |
| 13/03 | Handel Wall Street volatiel | |
| 13/03 | LATE BRIEFING - Unternehmen und Märkte | |
| 13/03 | MÄRKTE EUROPA/Ausverkauf nach SVB-Schieflage - Banken brechen ein | |
| 13/03 | Dpa-AFX-Überblick: UNTERNEHMEN vom 13.03.2023 - 15.15 Uhr | |
| 13/03 | MÄRKTE EUROPA/DAX kämpft mit 15.000er-Marke - Lufthansa leiden unter Streiks | |
| 13/03 | Sector Update: Health Care Stocks Advance in Early Monday Morning Trade | |
| 13/03 | Sector Update: Health Care | |
| 13/03 | Traders Assess US Moves to Contain Bank Fallout, Prompting Lower Premarket Session for .. | |
| 13/03 | Futures Wall Street verdeeld | |
| 13/03 | ANALYSE/Regeneron hält Big Pharma mit deren Waffen in Schach | |
| 13/03 | Fed's US Bank Rescue Lifts Exchange-Traded Funds, Equity Futures Pre-Bell Monday | |
| 13/03 | MIDDAY BRIEFING - Unternehmen und Märkte -2- | |
| 13/03 | Top Premarket Gainers | |
| 13/03 | French Bourse Kicks Off Week Deep in Red after Silicon Valley Bank Collapse | |
| 13/03 | Sanofi to Acquire Provention Bio in $2.9 Billion Deal | |
| 13/03 | European Midday Briefing: Investors Weigh SVB Contagion Risk | |
| 13/03 | North American Morning Briefing: Investors Digest Emerge.. | |
| 13/03 | Sanofi to Boost General Medicines Portfolio Via $3 Billion Takeover of US-based Provent.. | |
| 13/03 | La francesa Sanofi compra la estadounidense Provention Bio por 2.900 millones de dólare.. | |
| 13/03 | Sanofi stärkt Diabetes-Geschäft mit Milliardenzukauf | |
| 13/03 | Bolsa de Madrid: El Equipo A | |
| 13/03 | Sanofi will Provention Bio kaufen | |
| 13/03 | Sanofi kauft Provention Bio für rund 2,9 Mrd USD | |
| 13/03 | Live Stock Market Blog - March 13, 2023 - Business AM | |
| 13/03 | MORNING BRIEFING - Deutschland/Europa -2- | |
| 13/03 | Sanofi to Acquire Provention Bio for Around $2.9 Billion | |
| 13/03 | France's Sanofi to acquire US-based Provention Bio for $2.9 billion | |
| 13/03 | Sanofi to Buy Autoimmune Disease-focused Provention Bio for $2.9 Billion | |
| 13/03 | Sanofi neemt Provention Bio over in miljardendeal | |
| 13/03 | Galderma posts 2022 revenue growth ahead of planned IPO | |
| 13/03 | Press Release : Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first di.. | |
| 13/03 | Sanofi (ENXTPA:SAN) entered into an agreement to acquire 97.023% stake in.. | |
| 09/03 | US Lawmakers Introduce Bill Capping Insulin Price at $20 Per Vial | |
| 09/03 | Sanofi : Rapport Financiére | |
| 08/03 | Bolsa de Madrid: Don't fight the Fed, o de manera discreta | |
| 07/03 | Sanofi, Regeneron Say US FDA Accepted Supplemental Biologics License Application for Du.. | |
| 07/03 | European Midday Briefing: Powell Testimony in Focus | |
| 07/03 | Bolsa de Madrid: Ha vuelto, pero ¿está contento? | |
| 07/03 | Sanofi, Regeneron Seek US FDA Nod for Dupixent's Use in Treating Hives | |
| 07/03 | Press Release : Dupixent® (dupilumab) application for treatment of chronic spontaneous urt.. | |
| 07/03 | Regeneron Pharmaceuticals, Inc. and Sanofi Announce U.S. Food and Drug Administration A.. | |
| 07/03 | Regeneron Pharmaceuticals, Inc. and Sanofi Announce U.S. Food and Drug Administration A.. | |
| 07/03 | Sanofi Announces U.S. Food and Drug Administration Has Accepted, for Review, the Supple.. | |
| 07/03 | Press Release : Dupixent® (dupilumab) application for treatment of chronic spontaneous urt.. | |
| 06/03 | Sanofi inaugura su nueva sede central en España con 800 trabajadores | |
| 06/03 | Merck's drug boosts exercise capacity in pulmonary hypertension patients | |
| 06/03 | Merck's drug boosts exercise capacity in pulmonary hypertension patients | |
| 06/03 | Stada profitiert von Krankheitswelle und starkem Russland-Geschäft | |
| 02/03 | Correction: Sanofi, Sobi's Rare Bleeding Disorder Drug Shown Safe for Kids in.. | |
| 02/03 | Successful Transaction : Adragos Pharma has officially taken over the Sanofi production si.. | |
| 02/03 | Sanofi, Sobi's Rare Bleeding Disorder Drug Shown Safe for Kids in Late-stage Study | |
| 02/03 | Positive topline results from pivotal XTEND-Kids phase 3 study of efanesoctocog alfa in.. | |
| 02/03 | Press Release : Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIOTM to.. | |
| 02/03 | Sobi and Sanofi Announces Positive Topline Results from Pivotal XTEND- Kids Phase 3 Stu.. | |
| 02/03 | Press Release : Completed XTEND-Kids Phase 3 study strengthens potential of ALTUVIIIOTM to.. | |
| 02/03 | Merck KGaA expects 2023 profit to slip as COVID demand wanes | |
| 01/03 | Lilly reducirá un 70% el precio de la insulina en EEUU a partir del cuarto trimestre | |
| 01/03 | Eli Lilly to Cut Some Insulin Prices by 70% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
